Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|April 28, 2005
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, et al.
Plos Neglected Tropical Diseases|March 1, 2019
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activityThomas W von Geldern, Howard E Morton, Rick F Clark, et al.
Journal of Medicinal Chemistry|May 1, 2009
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitorsJohn T Randolph, Charles A Flentge, Peggy P Huang, et al.
The Journal of Infectious Diseases|October 15, 2013
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validationKayode K Ojo, Richard T Eastman, Ramasubbarao Vidadala, et al.
Antimicrobial Agents and Chemotherapy|March 15, 2023
Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Deborah A Schaefer, et al.
Journal of Medicinal Chemistry|February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazinesRolf Wagner, Daniel P Larson, David W A Beno, et al.
International Journal for Parasitology|September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosisMatthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Pageof 8